ALQGC: New Capital and New Investors Added By John Vandermosten, CFA EPA:ALQGC READ THE FULL ALQGC RESEARCH REPORT Benzinga · Apr 28, 2022
Injured climber winched to safety after Grampians plunge An injured climber has been winched to safety after falling in the Grampians National Park in Victoria's west last night. ABC News · Apr 28, 2022
AMTI: AMTI is Underappreciated By Brad Sorensen, CFA NASDAQ:AMTI READ THE FULL AMTI RESEARCH REPORT Benzinga · Apr 19, 2022
WKSP: April Update By Thomas Kerr, CFA NASDAQ:WKSP READ THE FULL WKSP RESEARCH REPORT Benzinga · Apr 7, 2022
ENSC: Ensysce Releases Encouraging Financials By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT Benzinga · Apr 6, 2022
TENX: 2021 Financial and Operational Review By John Vandermosten, CFA NASDAQ:TENX READ THE FULL TENX RESEARCH REPORT Benzinga · Apr 1, 2022
MITO: Stealth BioTherapeutics' Treatments Gain Momentum By Brad Sorensen, CFA NASDAQ:MITO READ THE FULL MITO RESEARCH REPORT Benzinga · Apr 1, 2022
LGVN: LGVN Publishes Positive Alzheimer's Results By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT Benzinga · Apr 1, 2022
UK Withdraws Its Judges From Hong Kong’s Top Court Britain said keeping its judges in Hong Kong’s Court of Final Appeal would “legitimize oppression” under a controversial security law in the former colony. The News Lens · Mar 31, 2022
EMMA: Emmaus Sickle Cell Treatment Expands Reach By Brad Sorensen, CFA OTC:EMMA READ THE FULL EMMA RESEARCH REPORT Benzinga · Mar 28, 2022
COCP: Cocrystal Pharma releases 2021 fiscal year results and provides an update on the current pipeline programs By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT Benzinga · Mar 25, 2022
IONGF: ION Energy is exploring & advancing two prospective lithium brine projects in Mongolia: the Baavhai Uul Project and the Urgakh Naran Project. By Steven Ralston, CFA OTCQB:IONGF | TSXV:ION READ THE FULL IONGF RESEARCH REPORT Benzinga · Mar 21, 2022
BIOX: Bioceres Crop Solutions to Merge with Marrone Bio Innovations in order to acquire a solid bio-crop protection product portfolio, additional bio-R&D capabilities and other By Steven Ralston, CFA NASDAQ:BIOX READ THE FULL BIOX RESEARCH REPORT Benzinga · Mar 18, 2022
BBLG: Bone Biologics Inks Important Supply Agreement By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Benzinga · Mar 18, 2022
Benzinga · Mar 17, 2022 BLRX: 2021 Results By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT
Benzinga · Mar 17, 2022 RVPH: 2021 Results By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT
Benzinga · Mar 15, 2022 TLSA: KOL Discussion and SPMS 6-Month Results By John Vandermosten, CFA NASDAQ:TLSA Introduction
Benzinga · Mar 11, 2022 ACHV: 2021 Results: ORCA-3 Underway, ORCA-V1 Soon to Start By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT
Benzinga · Mar 11, 2022 LGVN: Longeveron Continues to Make Progress By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT
Benzinga · Mar 11, 2022 CANG: December Quarter Results Met Expectations, but Soft Revenue Guidance for March Quarter Should Mark a Quarterly Trough for 2022 By T. Moore, CFA NYSE:CANG READ THE FULL CANG RESEARCH REPORT
Benzinga · Mar 11, 2022 LPCN: 2021 Results By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT
Benzinga · Mar 7, 2022 WKSP: Worksport updates investors and stakeholders with multiple press releases By Thomas Kerr, CFA NASDAQ:WKSP READ THE FULL WKSP RESEARCH REPORT
Benzinga · Mar 7, 2022 DRIO: Future Brightens with $40M Raise & Sanofi Deal By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT
Benzinga · Mar 7, 2022 NOVN: A Banner Year for Novan - 2021 Results By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT
Benzinga · Feb 24, 2022 COCP: Cocrystal Pharma has secured funding to enter three clinical trials and fund planned operations through 2023 By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT